Journal for ImmunoTherapy of Cancer (Nov 2020)

566 MDK-202: An empirically-designed peptidyl agonist of the IL-2/15βγc receptor, devoid of Rα interaction, unrelated to IL-2 or IL-15, and fused to an Fc-domain for PK enhancement

  • William Dower,
  • Alice Bakker,
  • Steven Cwirla,
  • Prarthana Joshi,
  • Praechompoo Pongtornpipat,
  • Blake Williams,
  • Sandra Wang,
  • Michael Needels,
  • Ronald Barrett

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0566
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.